Who Can Give Allergy Shots? Scope of Practice, State Rules & Personnel Guide

Medical assistants can administer allergy shots in many states, but their scope of practice for subcutaneous injection is the most variable across US states. Some states explicitly permit MAs to give subcutaneous injections under direct physician supervision (physician physically on-site); others restrict allergy injection administration to licensed nurses (RNs or LPNs). The American Association of Medical Assistants (AAMA) notes that MA scope is primarily determined by state law and employer policy rather than national standards. Before delegating injection administration to an MA, the allergy practice must verify its specific state's medical practice act and medical board regulations. All personnel giving shots must meet AAAAI training requirements for anaphylaxis recognition and epinephrine administration, regardless of credential.

Yes — nurse practitioners can prescribe and administer allergen immunotherapy in states with full practice authority (where NPs practice independently without required physician collaboration). In states with reduced or restricted practice authority, NPs may need a physician collaboration agreement for prescribing but can still administer injections within their practice scope. NPs who work in allergy practices and have completed appropriate allergy-specific training are well-positioned to both direct and deliver immunotherapy programs. The key AAAAI requirement — that a physician be immediately available on-site during administration — may apply differently to independent NP practices in full-practice-authority states, so the specific state and practice configuration matters for compliance.

The doctor does not need to be in the same room, but must be immediately available — which is consistently interpreted as physically on-site in the facility during injection administration. AAAAI practice parameters specify that allergen immunotherapy must be administered in a setting where anaphylaxis can be immediately treated, with a physician available to manage emergency responses. Some practices have sought broader interpretations, but phone or telemedicine availability does not satisfy the immediate availability standard because anaphylaxis can progress to cardiovascular collapse in under 10 minutes. The physician's on-site presence allows for immediate response if the nursing staff administering the injection calls for emergency assistance.

No — pharmacists are not authorized to administer allergen immunotherapy in any US state. While pharmacists can give vaccines and some other medications via injection, their scope of practice does not include allergen immunotherapy administration for several reasons. Pharmacists are not trained in immunotherapy extract handling, dose escalation protocols, or allergen-specific reaction management. Retail pharmacies also lack the physician supervision structure and emergency response infrastructure required for SCIT. Some states are exploring pharmacist-administered sublingual immunotherapy as a future model, but this is not currently available in the US. If you are looking for where pharmacies do and don't fit into allergy care, the relevant pharmacy services are dispensing antihistamines and nasal sprays, not administering immunotherapy.

Physician assistants can administer allergy shots, and in many states can prescribe allergen immunotherapy under a supervising physician's collaborative practice agreement. PAs who work in allergy practices with appropriate allergy-specific training are commonly involved in both prescribing and administering immunotherapy. Whether a PA can administer injections independently (without the physician on-site) depends on the specific state practice act and the terms of the collaborative agreement. AAAAI's requirement that a physician be immediately available on-site applies regardless of the PA's scope — the physician's on-site presence is a safety requirement for the administration setting, not a credential requirement for the injecting provider.

AAAAI requires that all personnel administering allergen immunotherapy be trained in recognizing and treating systemic reactions including anaphylaxis. The training components include: understanding of allergen immunotherapy mechanism and standard protocols, proper subcutaneous injection technique with aseptic standards, pre-injection patient screening, post-injection monitoring and anaphylaxis recognition, and emergency epinephrine administration. This training is typically delivered on-the-job in the allergy practice, supplemented by AAAAI and ACAAI educational resources. Annual competency verification is recommended, including supervised demonstration of anaphylaxis recognition and epinephrine administration. BLS (Basic Life Support) certification is typically required for all clinical staff in settings that administer SCIT. New staff members should complete a supervised observation period before independent injection administration.